Educational research grant for Australian Boceprevir CUPIC Study evaluating safety outcomes in patients with chronic Hepatitis C Genotype 1 receiving Boceprevir based triple therapy

Project: Research

StatusFinished
Effective start/end date31/05/1330/04/14

Funding

  • MSD (Merck Sharp & Dohme (Australia) Pty Ltd): AUD90,000.00